An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis
Clinical trial NCT00723528 · COMPLETED
Trial details
- NCT number
- NCT00723528
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-01-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.